References
- LükeMJanuschowskiKLükeJThe effects of ranibizumab (Lucentis) on retinal function in isolated perfused vertebrate retinaBr J Ophthalmol200993101396140019628500
- MaturiRKBleauLAWilsonDLElectrophysiologic findings after intravitreal bevacizumab (Avastin) treatmentRetina200626327027416508425
- MoschosMMBrouzasDApostolopoulosMKoutsandreaCLoukianouEMoschosMIntravitreal use of bevacizumab (Avastin) for choroidal neovascularization due to ARMD: a preliminary multifocal-ERG and OCT studyDoc Ophthalmol20071141374417216267
- FeiglBGreavesABrownBFunctional outcomes after multiple treatments with ranibizumab in neovascular age-related macular degeneration beyond visual acuityClin Ophthalmol20071216717519668506
- SutterEETranDThe field topography of ERG components in man-I. The photopic luminance responseVision Res19923234334461604830
- KaiserPKBrownDMZhangKRanibizumab for predominantly classic neovascular age-related macular degeneration: Subgroup analysis of first-year ANCHOR resultsAm J Ophthalmol2007144685085717949673
- MarmorMFHoodDCKeatingDKondoMSeeligerMWMiyakeYInternational Society for Clinical Electrophysiology of VisionGuidelines for basic multifocal electroretinography (mfERG)Doc Ophthalmol2003106210511512678274
- GerthCHauserDDelahuntPBMorseLSWernerJSAssessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusenArch Ophthalmol2003121101404141414557176
- JungCSBruceBNewmanNJBiousseVVisual function in anterior ischemic optic neuropathy: Effect of vision restoration therapy (VRT) – A pilot studyJ Neurol Sci20082681–214514918207164